| RS2519326222 |
PIGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, PIGA-related disorder |
| RS2519331621 |
PIGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, PIGA-related disorder |
| RS2519331657 |
PIGA
|
Health Risk |
Likely pathogenic |
Paroxysmal nocturnal hemoglobinuria 1, Paroxysmal nocturnal hemoglobinuria 1 |
| RS2519331818 |
PIGA
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Multiple congenital anomalies-hypotonia-seizures syndrome 2 |
| RS2519331896 |
PIGA
|
Health Risk |
Likely pathogenic |
Paroxysmal nocturnal hemoglobinuria 1, Paroxysmal nocturnal hemoglobinuria 1 |
| RS2519331917 |
PIGA
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Multiple congenital anomalies-hypotonia-seizures syndrome 2 |
| RS2519331925 |
PIGA
|
Health Risk |
Likely pathogenic |
Paroxysmal nocturnal hemoglobinuria 1, Paroxysmal nocturnal hemoglobinuria 1 |
| RS2519331987 |
PIGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Multiple congenital anomalies-hypotonia-seizures syndrome 2 |
| RS2519335932 |
USP9X
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 99 |
| RS2519339591 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2519339692 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2519339792 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2519339796 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2519341308 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2519343566 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2519343661 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2519343724 |
GATA1
|
Health Risk |
Pathogenic |
GATA binding protein 1 related thrombocytopenia with dyserythropoiesis, Diamond-Blackfan anemia |
| RS2519343730 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2519343771 |
GATA1
|
Health Risk |
Pathogenic |
GATA binding protein 1 related thrombocytopenia with dyserythropoiesis, Diamond-Blackfan anemia |
| RS2519343795 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2519343812 |
GATA1
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2519343818 |
GATA1
|
Health Risk |
Likely pathogenic |
X-linked dyserythropoetic anemia with abnormal platelets and neutropenia, X-linked dyserythropoetic anemia with abnormal platelets and neutropenia |
| RS2519343836 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2519343848 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2519343851 |
GATA1
|
Health Risk |
Likely pathogenic |
GATA1-related disorder, GATA1-related disorder |
| RS2519343869 |
GATA1
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2519343917 |
GATA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2519344800 |
GATA1
|
Health Risk |
Pathogenic |
GATA binding protein 1 related thrombocytopenia with dyserythropoiesis, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2519344834 |
GATA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS2519344939 |
GATA1
|
Health Risk |
Likely pathogenic |
— |
| RS2519345698 |
GATA1
|
Health Risk |
Likely pathogenic |
— |
| RS2519345787 |
GATA1
|
Health Risk |
Pathogenic |
Thrombocytopenia, X-linked |
| RS2519346409 |
GATA1
|
Health Risk |
Pathogenic |
Thrombocytopenia, X-linked |
| RS2519351408 |
GK
|
Health Risk |
Likely pathogenic |
— |
| RS2519358174 |
CNKSR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked |
| RS2519358649 |
CNKSR2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2519366750 |
USP9X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 99 |
| RS2519366804 |
USP9X
|
Health Risk |
Likely pathogenic |
— |
| RS2519366970 |
HDAC6
|
Health Risk |
Pathogenic |
X-linked dominant chondrodysplasia, Chassaing-Lacombe type |
| RS2519371254 |
USP9X
|
Health Risk |
Likely pathogenic |
— |
| RS2519371283 |
USP9X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 99 |
| RS2519371757 |
KDM5C
|
Health Risk |
Likely pathogenic |
— |
| RS2519373425 |
KDM5C
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2519374784 |
KDM5C
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2519375513 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2519375555 |
USP9X
|
Health Risk |
Likely pathogenic |
USP9X-related disorder, USP9X-related disorder |
| RS2519376156 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2519376608 |
DEPDC5
|
Health Risk |
Likely pathogenic |
— |
| RS2519378333 |
DEPDC5
|
Health Risk |
Likely pathogenic |
— |
| RS2519378518 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2519378722 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS2519378830 |
DEPDC5
|
Health Risk |
Likely pathogenic |
— |
| RS2519379527 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS2519380176 |
KDM5C
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2519380477 |
BCOR
|
Health Risk |
Pathogenic |
— |
| RS2519380502 |
FTSJ1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 9 |
| RS2519380736 |
KDM5C
|
Health Risk |
Likely pathogenic |
— |
| RS2519380755 |
KDM5C
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2519382131 |
FTSJ1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2519382563 |
USP9X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 99 |
| RS2519384114 |
KDM5C
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2519384720 |
FTSJ1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2519387409 |
PLXNB2
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2519391305 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2519393316 |
FTSJ1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 9 |
| RS2519396147 |
KDM5C
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Thyroid cancer |
| RS2519397087 |
CLCN5
|
Health Risk |
Likely pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2519397094 |
CLCN5
|
Health Risk |
Likely pathogenic |
— |
| RS2519397631 |
KDM5C
|
Health Risk |
Pathogenic |
— |
| RS2519397716 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2519399940 |
KDM5C
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2519400065 |
USP9X
|
Health Risk |
Likely pathogenic |
— |
| RS2519406899 |
CLCN5
|
Health Risk |
Likely pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2519406951 |
CLCN5
|
Health Risk |
Pathogenic |
— |
| RS2519412851 |
USP9X
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 99 |
| RS2519413099 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS2519417240 |
KDM5C
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2519418774 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2519419185 |
CLCN5
|
Health Risk |
Likely pathogenic |
— |
| RS2519419481 |
CLCN5
|
Health Risk |
Pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2519421361 |
NLGN4X
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2519421939 |
CLCN5
|
Health Risk |
Likely pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2519421979 |
NLGN4X
|
Health Risk |
Pathogenic |
— |
| RS2519422022 |
CLCN5
|
Health Risk |
Likely pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2519422486 |
CLCN5
|
Health Risk |
Pathogenic/Likely pathogenic |
Dent disease type 1, Hypophosphatemic rickets |
| RS2519431860 |
CLCN5
|
Health Risk |
Pathogenic |
— |
| RS2519433029 |
CLCN5
|
Health Risk |
Likely pathogenic |
— |
| RS2519433160 |
CLCN5
|
Health Risk |
Pathogenic |
— |
| RS2519433497 |
CLCN5
|
Health Risk |
Pathogenic |
— |
| RS2519434099 |
CLCN5
|
Health Risk |
Likely pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2519434808 |
CLCN5
|
Health Risk |
Pathogenic |
— |
| RS2519434988 |
CLCN5
|
Health Risk |
Likely pathogenic |
Proteinuria, low molecular weight |
| RS2519435022 |
CLCN5
|
Health Risk |
Pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2519435176 |
CLCN5
|
Health Risk |
Pathogenic |
— |
| RS2519435406 |
CLCN5
|
Health Risk |
Likely pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2519435651 |
PLXNB2
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2519440356 |
CLCN5
|
Health Risk |
Likely pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS2519440480 |
CLCN5
|
Health Risk |
Likely pathogenic |
Dent disease type 1, Hypophosphatemic rickets |
| RS2519440912 |
CLCN5
|
Health Risk |
Likely pathogenic |
— |
| RS2519442928 |
PORCN
|
Health Risk |
Pathogenic |
Focal dermal hypoplasia, Focal dermal hypoplasia |